#HEMERA BIOSCIENCES ARCHIVE#
Community submitted dataĪssociated sectors: Life Sciences Biologics Healthtech SARS-CoV-2 Vaccine Cancer Melanoma Immunotherapy Diagnostics DNA RNA Peptide Therapies Vaccines Biotech Website archive shows the site was first archived on 2016. We work directly with corporations and also with service providers (such as open innovation agencies, outsourced R&D consultants, and traditional crowd-sourcing companies) to provide them with our intelligent company discovery capabilities. It has already passed a phase 1 test, with a second in patients with wet AMD currently conducting follow-up visits to evaluate long-term safety, according to a statement. The mission of PFP Biosciences is to bring to market innovative pharmaceutical treatments addressing diseases or conditions with significant unmet clinical needs with the potential to improve the.
#HEMERA BIOSCIENCES FREE#
By structuring and analysing this information we are able to accurately match our clients needs with the start-ups, SMEs and other innovators that have the skills our clients need. Free and open company data on Massachusetts (US) company HEMERA BIOSCIENCES, LLC (company number 001411751), 800 SOUTH ST. HMR59 is designed to increase the ability of retina cells to make a soluble form of CD59, with the theory being it can help stop further damage and retain a patients vision. We discover innovative companies from across the globe using our Company Discovery Engine, which trawls the web to harvest and aggregate company information at a scale, speed and efficiency that hasn’t previously been possible. He assumed the role of CEO in 2017 and oversaw all aspects of. VentureRadar helps organisations innovate and generate new growth by connecting them to the emerging technologies and expertise that can solve their challenges. Rogers co-founded Hemera Biosciences in 2010, a clinical stage gene therapy company targeting dry age-related macular degeneration.
0 kommentar(er)
